
Medicare’s drug price rule could raise costs in 19 nations
Medicare’s drug price benchmark could trigger a chain reaction across 19 countries.
Funso Lawal is a Healthcare-Finance Contributor at FinanceTracked, specializing in translating complex, fast-moving financial and market topics into clear, well-researched narratives for a broad readership. His work spans stock market analysis, NGX equities, personal finance, investing, retirement planning, and cryptocurrency, with previous contributions to Benzinga covering topics that help readers make sense of an evolving financial landscape. At TobiWrites LLC, he produced crypto-focused educational content to support readers' trading decisions, consistently meeting daily deadlines while growing readership through search-optimized, audience-first writing. At FinanceTracked, Funso covers healthcare stocks, NGX-listed equities, international equity analysis, and broader personal finance topics. He brings a research-first approach to every piece, using industry trends and performance data to identify content gaps and keep coverage timely and relevant. He is skilled in SEO-driven writing, WordPress publishing, and editorial collaboration, and adapts quickly to shifting priorities without compromising accuracy or depth.

Medicare’s drug price benchmark could trigger a chain reaction across 19 countries.

Health insurance premiums in Nigeria are outpacing inflation as drug prices, hospital tariffs, and NHIA fee adjustments push costs higher for households and employers alike.

A single formula can tell you whether your retirement plan will actually hold up or fall short.